Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
| ▸ | CDC25C | P30307 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hypophosphorous Acid SCHEMBL11745487 | 0.86 | CDC25A (0.30) | CDC25ACDC25BCDC25C | |
| Hypophosphorous Acid SCHEMBL158544 | 0.86 | CDC25A (0.30) | CDC25ACDC25BCDC25C | |
| Hypophosphorous Acid SCHEMBL11423434 | 0.86 | CDC25A (0.30) | CDC25ACDC25BCDC25C | |
| Hypophosphorous Acid SCHEMBL3405787 | 0.86 | — | — | |
| Hypophosphorous Acid SCHEMBL829092 | 0.86 | — | — | |
| Hypophosphorous Acid SCHEMBL245228 | 0.86 | — | — | |
| Hypophosphorous Acid SCHEMBL8330619 | 0.86 | CDC25A (0.30) | CDC25ACDC25BCDC25C | |
| Hypophosphorous Acid SCHEMBL11413147 | 0.86 | CDC25A (0.30) | CDC25ACDC25BCDC25C | |
| Hypophosphorous Acid SCHEMBL41452 | 0.86 | — | — | |
| Hypophosphorous Acid SCHEMBL11655918 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140350241-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS LLC | 2014-11-27 | — | — | US | disclosed |
| EP-2393822-B1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS INC (US) | 2014-07-16 | — | — | EP | disclosed |
| US-20130267698-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS LLC | 2013-10-10 | — | — | US | disclosed |
| US-20130150572-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2013-06-13 | — | — | US | disclosed |
| US-20130030209-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| US-20120041191-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2012-02-16 | — | — | US | disclosed |
| EP-2393822-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX Pharmaceuticals, Inc. (US) | 2011-12-14 | — | — | EP | disclosed |
| EP-2393822-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX Pharmaceuticals, Inc. (US) | 2011-12-14 | — | — | EP | disclosed |
| WO-2010090976-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
| WO-2010090976-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | IDENIX PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130150572-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, POP1 | CDC25A 863/4885CDC25B 1204/4885CDC25C 1126/4885 |
| US-20140350241-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, POP1 | CDC25A 863/4885CDC25B 1204/4885CDC25C 1126/4885 |
| US-20130267698-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, POP1 | CDC25A 863/4885CDC25B 1204/4885CDC25C 1126/4885 |
| US-20120041191-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, PHOSPHO1 | CDC25A 793/4885CDC25B 1043/4885CDC25C 964/4885 |
| US-20130030209-A1 | PHOSPHINATE RUTHENIUM COMPLEXES | RPIA, NDUFS7, POP1 | CDC25A 863/4885CDC25B 1204/4885CDC25C 1126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.